Delivery Order SPE2DB24D2106-SPE2DB25FAWFJ
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,096.20 to DMS Pharmaceutical Group Inc. for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for ultimate completion by August 8, 2025, and represents a single line-item purchase drawn from the company's existing...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,365.40 award is for the supply of the prescription drug Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The delivery order has a completion date of May 9, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,870.48 firm fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,547.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to support the medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,749.94 order is for the drug Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a completion date of August 23, 2024. DMS Pharmaceutical Group holds a $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,870.48 firm fixed-price contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The $1,262.06 firm fixed-price delivery order has a completion date of September 23, 2021 and was awarded on September 22, 2021. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- This is a $18,614.39 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of January 16, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,682.70 contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, with a period of performance through June 18, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, enabling the agency to issue delivery orders...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,483.18, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 1, 2022. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWFJDelivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $15,485.53 for Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. The contract, awarded on September 3, 2025, carries a firm fixed price and is not set-aside designated. Performance will take place in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. DMS Pharmaceutical Group, based in Park Ridge, Illinois and registered in SAM.gov since 2001, serves as a critical supplier in the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This delivery order for Ozempic supports the Department of Defense healthcare system's pharmaceutical supply needs, consistent with the company's established portfolio of medication deliveries ranging from specialty pharmaceuticals to vaccines and injectable medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 9/3/25 |